Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mohini Mendiratta
Observed name:
Mendiratta, Mohini
Institutions:
DR. B.R.A. Institute Rotary Cancer Hospital,
All India Institute of Medical Sciences
Observed institutions:
DR. B.R.A. Institute Rotary Cancer Hospital,
All India Institute of Medical Sciences
ORCID:
0000-0002-1494-5158
Observed ORCID:
0000-0002-1494-5158
OpenAlex ID:
A5019281133
In vitro anticancer efficacy of a polyphenolic combination of Quercetin, Curcumin, and Berberine in triple negative breast cancer (TNBC) cells
2022
·
Akanksha Kashyap
, Sheikh Mohammad Umar
, et al.
·
Phytomedicine Plus
·
28
Bergenin inhibits growth of human cervical cancer cells by decreasing Galectin-3 and MMP-9 expression
2024
·
Ravi Chauhan
, Lakshay Malhotra
, et al.
·
Scientific Reports
·
27
Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease model
2024
·
Mohini Mendiratta
, Meenakshi Mendiratta
, et al.
·
Stem Cell Research & Therapy
·
13
PDF
Breaking the graft-versus-host-disease barrier: Mesenchymal stromal/stem cells as precision healers
2023
·
Mohini Mendiratta
, Meenakshi Mendiratta
, et al.
·
International Reviews of Immunology
·
11
PDF
Application of Bio-Active Elastin-like Polypeptide on Regulation of Human Mesenchymal Stem Cell Behavior
2022
·
Vijaya Sarangthem
, Harshita Sharma
, et al.
·
Biomedicines
·
8
PDF
Uncovering the bequeathing potential of apoptotic mesenchymal stem cells via small extracellular vesicles for its enhanced immunomodulatory and regenerative ability
2025
·
Meenakshi Mendiratta
, Mohini Mendiratta
, et al.
·
Stem Cell Research & Therapy
·
5
PDF
Hypoxia-Mediated Molecular Interactions of Tissue-Specific Mesenchymal Stem Cells Drive Metabolic Reprogramming and Immunomodulation in Acute Graft-versus-Host Disease
2025
·
Mohini Mendiratta
, Meenakshi Mendiratta
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
5
The Integral Role of Mesenchymal Stem Cells in Stem Cell Transplantation from Promotion of Stem Cell Engraftment to Immunomodulation
2024
·
Mohini Mendiratta
, Meenakshi Mendiratta
, et al.
·
Biochemistry
·
3
A Comparative assessment of T-Cell response of Healthy donors and Acute Graft-versus-Host-Disease Patients: Customizing immune monitoring platform
2024
·
Mohini Mendiratta
, Meenakshi Mendiratta
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
Hypoxia-induced metabolic and apoptotic reprogramming enhances immunomodulation in Wharton’s jelly mesenchymal stem cells
2026
·
Mohini Mendiratta
, Meenakshi Mendiratta
, et al.
·
iScience
·
1
PDF
Membrane phospholipids in the regulation of tissue factor procoagulant function
2026
·
Shabbir A. Ansari
, Mohini Mendiratta
, et al.
·
Current Opinion in Hematology
·
1
Cytokine Signatures Outperform Immune Subsets in Machine Learning Models for Predicting Acute Graft‐Versus‐Host Disease at Neutrophil Engraftment
2026
·
Mohini Mendiratta
, Praful Pandey
, et al.
·
Journal of Immunology Research
·
1
Dose-response immunomodulatory effects of Mesenchymal stem cell-derived culture-conditioned media in acute Graft-versus-Host Disease
2025
·
Mohini Mendiratta
, Meenakshi Mendiratta
, et al.
·
Regenerative Therapy
·
1
Hemophagocytic Histiocytosis in Acute Myeloid Leukemia: A Prospective Study Integrating Clinico-Laboratory and Flow Cytometry Findings
2024
·
Sabitha Paramasivam
, Ranjit Kumar Sahoo
, et al.
·
Blood
·
1
PDF
Umbilical Cord–Derived Mesenchymal Stromal Cells For Prevention of Chronic Graft-vs-Host Disease
2024
·
Mohini Mendiratta
, Sujata Mohanty
, et al.
·
JAMA Oncology
·
1
CML-362 Study to Evaluate the Effect of Fatty Meals on Nilotinib Drug Levels in Patients of Chronic Myeloid Leukemia–Chronic Phase and Correlate Its In-Vivo Activity With STAT1, STAT5, and AKT 1 Levels
2022
·
Ankur Nandan Varshney
, Laxmi Moksha
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
AML-1170: Machine Learning–Based Prediction of Induction Mortality in Acute Myeloid Leukemia Using Baseline Clinical and Laboratory Biomarkers
2026
·
Inam Ullah Khan
, Sabitha Paramasivam
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Dual Preconditioned Mesenchymal Stem Cells-Derived Culture Conditioned Media Augment Immunomodulation and Drive Metabolic Reprogramming in Acute Graft-versus-Host Disease
2025
·
Mohini Mendiratta
, Meenakshi Mendiratta
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Secretome of Hypoxia-Preconditioned Apoptotic Wharton's Jelly Mesenchymal Stem Cells: A Superior Non-Cellular Approach for Managing Acute Graft-Versus-Host Disease
2025
·
Ranjit Kumar Sahoo
, Mohini Mendiratta
, et al.
·
Transplantation and Cellular Therapy
Machine Learning Algorithm-Based Prediction of Acute Graft-Versus-Host-Disease at Engraftment through Immune and Cytokine Profile
2024
·
Mohini Mendiratta
, Praful Pandey
, et al.
·
Blood
PDF
CT-634 Cytomegalovirus Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation and Its Association With Donor Virus-Specific Cellular Immunity
2024
·
Archana Sasi
, Mohini Mendiratta
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
AML-757 Venetoclax With Chemotherapy for Remission Induction in AML Patients: The Phase Ib/II (RAPID VEN) Study
2024
·
Paramasivam Sabitha
, Mohini Mendiratta
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Cytomegalovirus Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation and Its Association With Donor Virus-Specific Cellular Immunity
2024
·
Archana Sasi
, Mohini Mendiratta
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Venetoclax With Chemotherapy for Remission Induction in AML Patients: The Phase Ib/II (RAPID VEN) Study
2024
·
Paramasivam Sabitha
, Mohini Mendiratta
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
27
Citation count:
109
H-index:
5
I10-index:
4
Year
Topic
Type